Transcatheter Oily Chemoembolization and ? 1-Thymosin in treating HCC
- Author:
Nguyen Hong Bang
- Publication Type:Journal Article
- Keywords:
hepato cellular carcinomas ( HCC)
- MeSH:
Liver Neoplasms;
Thymosin;
Therapeutics
- From:Journal of Medical and Pharmaceutical Information
2003;0(6):31-35
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
The aim of this study is to evaluate the therapeutic potential of the immunostimulating adjuvant in patients with HCCs¬¬¬.46 patients with HCCs were divided into 2 groups: group I (30pts) treated by Transcatheter Oily Chemoembolization (TOCE alone), group II resulted in a better clinical improvement, decreased AFP and tumor size, and a longer mean survival time versus group I. Combined treatment demonstrated a significant increase in lymphocytes expressing CD 16-CD 56 with NK activity and followed by a rise in lymphocyte with morphological feature of cytotoxic lymphocyte ( CD8 positive) was observed
